The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus

Eun-Jung PARK; Hyungjin KIM; Seung-Min JUNG; Yoon-Kyoung SUNG; Han-Joo BAEK; Jisoo LEE.
The Korean Journal of Internal Medicine ; : 41-59, 2020.
Artículo | WPRIM | ID: wpr-831754

Documentos relacionados

  1. The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus.
  2. The Use of Biological Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in Korea: Results of a Korean Expert Consensus
  3. Biomedical research in france and brazil: an analysis of significant differences and ethical issues
  4. [Factors influencing pregnancy stress in pregnant women in Korea: a cross-sectional study].
  5. [Training of Radiofrequency Ablation for Thyroid Nodules in Korea: Current and Future Perspective].
  6. [Childbirth outcomes and perineal damage in women with natural childbirth in Korea: a retrospective chart review].
  7. [Burnout among Radiologists in Korea: Prevalence, Risk Factors, and Remedies].
  8. [National Health Insurance System of Korea: Resource-Based Relative Value Scale and a New Healthcare Policy].
  9. Conocimiento sobre el uso de fármacos off-label en Pediatría. Resultados de una encuesta pediátrica nacional 2012-2013 (estudio OL-PED)